Opko Health ( (OPK) ) has shared an update.
BioReference Health, an OPKO Health subsidiary, has successfully settled its debts by repaying roughly $9.7 million and terminating its Credit Agreement, coinciding with the sale of its lab testing businesses to Laboratory Corporation of America Holdings for $237.5 million. This strategic move, enhancing both companies’ focus and reach within the diagnostics sector, was announced in a recent press release, marking a significant shift in the landscape of clinical diagnostics and reproductive health services in the U.S., excluding New York and New Jersey.
Find detailed analytics on OPK stock on TipRanks’ Stock Analysis page.
